Hui-hui Xu
Linhai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Genetic variations and carcinogenicity analysis of E6/E7 oncogenes in HPV31 and HPV35 in Taizhou, China.
Journal: Virology journal
Published: December 13, 2024
The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation.
Journal: Frontiers in immunology
Published: April 23, 2024
A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Journal: Frontiers in immunology
Published: January 10, 2022
Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
Journal: Frontiers in immunology
Published: October 07, 2020
Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions.
Journal: Frontiers in immunology
Published: June 03, 2020
The Role of HLA-G in Human Papillomavirus Infections and Cervical Carcinogenesis.
Journal: Frontiers in immunology
Published: March 24, 2020
Association of HLA-G 3' UTR polymorphism and expression with the progression of cervical lesions in human papillomavirus 18 infections.
Journal: Infectious agents and cancer
Published: October 27, 2018
Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China.
Journal: Gene
Published: September 28, 2017
Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis.
Journal: Oncotarget
Published: May 09, 2017
Associations between epidermal growth factor receptor gene mutation and serum tumor markers in advanced lung adenocarcinomas: a retrospective study.
Journal: Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
Published: September 30, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026